185
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Diverse Virulence of Staphylococcus aureus Strains for the Conjunctiva

, , , , &
Pages 14-20 | Received 26 Apr 2010, Accepted 09 Sep 2010, Published online: 21 Dec 2010

REFERENCES

  • Shetty AK, Kumar A. Osteomyelitis in adolescents. Adolesc Med State Art Rev. 2007;18:79–94.
  • Popovich KJ, Hota B, Weinstein RA. Treatment of community-associated methicillin-resistant Staphylococcus aureus. Curr Infect Dis Rep. 2008;10:411–420.
  • Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: A consequence of medical progress. JAMA. 2005;293:3012–3021.
  • Kielian T, Syed MM, Liu S, et al. The synthetic peroxisome proliferators-activated receptor gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses. J Immunol. 2008;180:5004–5016.
  • Gudmundsson OG, Ormerod LD, Kenyon KR, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea. 1989;8:115–121.
  • Friedlin J, Acharya N, Lietman TM, et al. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol. 2007;144:313–315.
  • Asbell PA, Sahm DF, Shaw M, et al. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J Cataract Refract Surg. 2008;34:814–818.
  • Cavuoto K, Zutshi D, Karp CL, et al. Update on bacterial conjunctivitis in South Florida. Ophthalmology. 2008;115:51–56.
  • Chisari G. Endophthalmitis: Gram-positive etiological agents and susceptibility to glycopeptides. Curr Clin Pharmacol. 2008;3:153–155.
  • Hautala N, Koskela M, Hautala T. Major age group-specific differences in conjunctival bacteria and evolution of antimicrobial resistance revealed by laboratory data surveillance. Curr Eye Res. 2008;33:907–911.
  • Lichtenstein SJ, Wagner RS, Jamison T, et al. Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: Clinical implications and a review of kinetics of kill studies. Adv Ther. 2007;24:1098–1111.
  • Denis F, Chaumeil C, Goldschmidt P, et al. Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis. Eur J Ophthalmol. 2008;18:858–868.
  • Dorfman MS, Wagner RS, Jamison T, et al. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment. Adv Ther. 2008;25:208–217.
  • Granet DB, Dorfman M, Stroman D, et al. A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis. J Pediatr Ophthalmol Strabismus. 2008;45:340–349.
  • Behrens-Baumann W, Begall T. Reproducible model of a bacterial conjunctivitis. Ophthalmologica. 1993;206:69–75.
  • O’Callaghan R, Callegan M, Moreau J, et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65:1571–1578.
  • Dajcs J, Austin M, Sloop G, et al. Corneal pathogenesis of Staphylococcus aureus strain Newman. Invest Ophthalmol Vis Sci. 2002;43:1109–1115.
  • Sloop GD, Moreau JM, Conerly LL, et al. Acute inflammation of the eyelid and cornea in Staphylococcus keratitis in the rabbit. Invest Ophthalmol Vis Sci. 1999;40:385–391.
  • McCormick CC, Balzli CL, Caballero AR, et al. The bactericidal effectiveness of an enhanced tobramycin-dexamethasone formulation. Invest Ophthalmol Vis Sci. 2008;49: ARVO E-Abstract 846.
  • Balzli CL, Bartell J, Dajcs J, et al. A highly virulent Staphylococcus aureus: Rabbit anterior chamber infection, characterization, and genetic analysis. Invest Ophthalmol Vis Sci. 2010 May 12. [Epub ahead of print]
  • Tang A, Caballero AR, McCormick CC, et al. A new topical model of Staphylococcus aureus keratitis in a scarified rabbit eye. Invest Ophthalmol Vis Sci. 2009;50: ARVO E-Abstract 2397.
  • Nwanegbo EC, Romanowski EG, Gordon YJ, et al. Efficacy of topical immunoglobulins against experimental adenoviral ocular infection. Invest Ophthalmol Vis Sci. 2007;48:4171–4176.
  • Niederkorn JY. Immune regulatory mechanisms in allergic conjunctivitis: Insights from mouse models. Curr Opin Allergy Clin Immunol. 2008;8:472–476.
  • Thomas PB, Zhu Z, Selvam S, et al. Autoimmune dacryoadenitis and keratoconjunctivitis induced in rabbits by subcutaneous injection of autologous lymphocytes activated ex vivo against lacrimal antigens. J Autoimmun. 2008;31:116–122.
  • Toma HS, Murina AT, Areaux RG, Jr. et al. Ocular HSV-1 latency, reactivation and recurrent disease. Semin Ophthalmol. 2008;23:249–273.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.